Pediatric antiphospholipid syndrome

Area of Science:

• Pediatric Rheumatology
• Immunology
• Hematology

Background:

• Pediatric antiphospholipid syndrome (APS) is a rare autoimmune condition with significant potential for childhood morbidity.
• The condition remains understudied, particularly concerning its epidemiology, clinical presentation, and management in pediatric populations.
• Understanding pediatric APS is crucial for differentiating it from adult APS and its occurrence in conjunction with lupus.

Purpose of the Study:

• To review the current knowledge on pediatric antiphospholipid syndrome (APS) epidemiology.
• To outline diagnostic approaches for clinicians managing suspected pediatric APS cases.
• To discuss clinical manifestations, treatment implications, and future research directions for pediatric APS.

Main Methods:

• Comprehensive literature review focusing on pediatric antiphospholipid syndrome (APS).
• Analysis of similarities and differences between pediatric and adult APS, including primary APS and APS in lupus.
• Examination of non-thrombotic clinical features, particularly neurological and hematological aspects.

Main Results:

• Pediatric APS presents unique clinical manifestations, including neurological and hematological issues, beyond typical thrombosis.
• Antiphospholipid antibody positivity has distinct implications for children with lupus and neonates born to mothers with APS.
• Treatment strategies for pediatric APS require careful consideration due to the specific effects of medications in children.

Conclusions:

• Pediatric antiphospholipid syndrome (APS) requires specialized attention due to its distinct clinical profile and treatment considerations.
• Further mechanistic research is essential to advance personalized care for children with APS.
• Bridging knowledge gaps in pediatric APS will improve diagnostic accuracy and therapeutic outcomes.